{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T11:00:57Z","timestamp":1772622057709,"version":"3.50.1"},"reference-count":44,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Bioeng. Biotechnol."],"abstract":"<jats:p>Cell and gene therapy (CGT) is a field of therapeutic medicine that aims to treat, prevent, and cure diseases using engineered cells (stem cells, immune cells, and differentiated adult or fetal cells), vectors [Adeno Associated Virus (AAV), Adeno Virus (AV), Herpes Simplex Virus (HSV), Baculo Virus (BV), Lenti Virus (LV), Retro Virus (RV), etc.], and other carriers [non-viral vectors, virus-like particles (VLP), Lipid Nano-Particles (LNP), etc.]. Among viral CGT vectors, adeno-associated viruses and lentiviruses (AAV and LV) are the most widely applied vector platforms. The presence of non-functional (empty or non-infectious) vectors that carry null or partial genes in the final drug product is classified as an impurity by the FDA. These impurities impair dosage accuracy and induce non-specific immunogenicity and variability in drug efficacy. These non-functional viral vectors in the drug product need to be elucidated following International Conference on Harmonization (ICH) guidelines for clinical manufacturing of the final drug product. This article showcases an ion-exchange chromatography (IEX) high-resolution method supporting ICH guidelines using commercially available AAV8 filled and empty capsids as reference standards. Our method successfully separated empty to full capsids with a resolution of 15 and sustained a linearity greater than 0.98 even under a wide range of empty or full viral particle concentrations (E+9 to E+13 vp\/mL), which is an upgrade to other IEX capsid separation methods. The medium-throughput capacity and shorter sample processing time improve testing efficiency and save costs while delivering quality as value. The discussed method is a reliable and reproducible platform to precisely evaluate the presence of non-functional viral particles in AAV8 samples. Aligned with other orthogonal results, the method is a powerful tool to improve the quality of rAAV analytics.<\/jats:p>","DOI":"10.3389\/fbioe.2024.1436857","type":"journal-article","created":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T04:42:18Z","timestamp":1727757738000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":7,"title":["An improved high-resolution method for quantitative separation of empty and filled AAV8 capsids by strong anion exchange HPLC"],"prefix":"10.3389","volume":"12","author":[{"given":"Samantha","family":"Schrecke","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin","family":"McManus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cassandra","family":"Moshfegh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica","family":"Stone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thuy-Uyen","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gustavo","family":"Rivas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ismaeel","family":"Muhamed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel A. J.","family":"Mitchell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2024,10,1]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"12332","DOI":"10.3390\/ijms232012332","article-title":"Anion-exchange chromatography at the service of gene therapy: baseline separation of full\/empty adeno-associated virus capsids by screening of conditions and step gradient elution mode","volume":"23","author":"Aebischer","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"B2","article-title":"Agilent OpenLab CDS data analysis reference guide","year":"2016"},{"key":"B3","doi-asserted-by":"publisher","first-page":"4313","DOI":"10.1182\/bloodadvances.2021004760","article-title":"Why is AAV FVIII gene therapy not approved by the US Food and Drug Administration yet?","volume":"5","author":"Arruda","year":"2021","journal-title":"Blood Adv."},{"key":"B4","doi-asserted-by":"publisher","first-page":"e15071","DOI":"10.1016\/j.heliyon.2023.e15071","article-title":"AAV genome modification for efficient AAV production","volume":"9","author":"Asaad","year":"2023","journal-title":"Heliyon"},{"key":"B42","doi-asserted-by":"publisher","first-page":"4310","DOI":"10.1021\/acs.analchem.2c04234","article-title":"Analysis of aav-extracted dna by charge detection mass spectrometry reveals genome truncations","volume":"95","author":"Barnes","year":"2023","journal-title":"Anal. Chem."},{"key":"B5","doi-asserted-by":"publisher","first-page":"283","DOI":"10.2217\/fvl-2017-0011","article-title":"Understanding capsid assembly and genome packaging for adeno-associated viruses","volume":"12","author":"Bennett","year":"2017","journal-title":"Future Virol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1089\/hum.2017.048","article-title":"AAV: an overview of unanswered questions","volume":"28","author":"Berns","year":"2017","journal-title":"Hum. Gene Ther."},{"key":"B7","article-title":"Control of empty, full and partially filled capsids \u2013 BioPhorum establishing an industry position on this critical quality attribute","year":"2022"},{"key":"B8","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1002\/9781118971147.ch5","article-title":"Q2(R1) validation of analytical procedures","volume-title":"ICH quality guidelines","author":"Borman","year":"2017"},{"key":"B9","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1089\/hgtb.2015.048","article-title":"Analytical ultracentrifugation as an approach to characterize recombinant adeno-associated viral vectors","volume":"26","author":"Burnham","year":"2015","journal-title":"Hum. Gene Ther. Methods"},{"key":"B10","doi-asserted-by":"publisher","first-page":"586","DOI":"10.3390\/pharmaceutics13040586","article-title":"Characterization of recombinant adeno-associated viruses (rAAVs) for gene therapy using orthogonal techniques","volume":"13","author":"Cole","year":"2021","journal-title":"Pharmaceutics"},{"key":"B43","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1021\/jasms.4c00151","article-title":"An online native mass spectrometry approach for fast, sensitive, and quantitative assessment of adeno-associated virus capsid content ratios","volume":"35","author":"Cotham","year":"2024","journal-title":"J. Am. Soc. Mass Spectrom."},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.12665\/J20OA.Gagnon","article-title":"Separation of empty and full adeno-associated virus capsids from a weak anion exchanger by elution with an ascending pH gradient at low ionic strength","volume":"20","author":"Gagnon","year":"2021","journal-title":"Bioprocess. J."},{"key":"B12","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/mtm.2013.9","article-title":"Empty virions in AAV8 vector preparations reduce transduction efficiency and may cause total viral particle dose-limiting side effects","volume":"1","author":"Gao","year":"2014","journal-title":"Mol. Ther. - Methods and Clin. Dev."},{"key":"B44","doi-asserted-by":"publisher","first-page":"5749","DOI":"10.1021\/jacs.3c08139","article-title":"Single-ion mass spectrometry for heterogeneous and high molecular weight samples","volume":"146","author":"Jarrold","year":"2024","journal-title":"J. Am. Chem. Soc."},{"key":"B13","doi-asserted-by":"publisher","first-page":"123511","DOI":"10.1016\/j.jchromb.2022.123511","article-title":"Ion exchange chromatography hyphenated with fluorescence detector as a sensitive alternative to UV detector: applications in biopharmaceutical analysis","volume":"1212","author":"Joshi","year":"2022","journal-title":"J. Chromatogr. B"},{"key":"B14","doi-asserted-by":"publisher","first-page":"101112","DOI":"10.1016\/j.omtm.2023.101112","article-title":"Adeno-associated viral capsid stability on anion exchange chromatography column and its impact on empty and full capsid separation","volume":"31","author":"Khanal","year":"2023","journal-title":"Mol. Ther. - Methods and Clin. Dev."},{"key":"B15","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1016\/j.omtm.2021.04.003","article-title":"Anion-exchange HPLC assay for separation and quantification of empty and full capsids in multiple adeno-associated virus serotypes","volume":"21","author":"Khatwani","year":"2021","journal-title":"Mol. Ther. - Methods and Clin. Dev."},{"key":"B16","doi-asserted-by":"publisher","first-page":"115421","DOI":"10.1016\/j.ab.2023.115421","article-title":"Separation of full and empty adeno-associated virus capsids by anion-exchange chromatography using choline-type salts","volume":"686","author":"Kurth","year":"2024","journal-title":"Anal. Biochem."},{"key":"B17","doi-asserted-by":"publisher","first-page":"18631","DOI":"10.1038\/s41598-019-54928-y","article-title":"Adeno-associated virus capsid protein expression in Escherichia coli and chemically defined capsid assembly","volume":"9","author":"Le","year":"2019","journal-title":"Sci. Rep."},{"key":"B18","doi-asserted-by":"publisher","first-page":"698","DOI":"10.3390\/v15030698","article-title":"Viral vectors in gene therapy: where do we stand in 2023?","volume":"15","author":"Lundstrom","year":"2023","journal-title":"Viruses"},{"key":"B19","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/s41434-024-00444-2","article-title":"Analytical characterization of full, intermediate, and empty AAV capsids","volume":"31","author":"McColl-Carboni","year":"2024","journal-title":"Gene Ther."},{"key":"B20","doi-asserted-by":"publisher","first-page":"662","DOI":"10.3390\/v12060662","article-title":"The interplay between adeno-associated virus and its helper viruses","volume":"12","author":"Meier","year":"2020","journal-title":"Viruses"},{"key":"B21","doi-asserted-by":"publisher","first-page":"e0077321","DOI":"10.1128\/JVI.00773-21","article-title":"Improved genome packaging efficiency of adeno-associated virus vectors using rep hybrids","volume":"95","author":"Mietzsch","year":"2021","journal-title":"J. Virology"},{"key":"B22","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1182\/blood-2013-01-306647","article-title":"Immune responses to AAV vectors: overcoming barriers to successful gene therapy","volume":"122","author":"Mingozzi","year":"2013","journal-title":"Blood"},{"key":"B23","doi-asserted-by":"publisher","first-page":"12260","DOI":"10.1128\/JVI.01304-07","article-title":"Structure of adeno-associated virus serotype 8, a gene therapy vector","volume":"81","author":"Nam","year":"2007","journal-title":"J. Virology"},{"key":"B24","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1007\/s40259-017-0234-5","article-title":"Adeno-Associated virus (AAV) as a vector for gene therapy","volume":"31","author":"Naso","year":"2017","journal-title":"BioDrugs"},{"key":"B25","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/j.ajps.2021.05.003","article-title":"Applications and developments of gene therapy drug delivery systems for genetic diseases","volume":"16","author":"Pan","year":"2021","journal-title":"Asian J. Pharm. Sci."},{"key":"B26","doi-asserted-by":"publisher","first-page":"7875","DOI":"10.1128\/JVI.00649-08","article-title":"Adeno-Associated virus vector genomes persist as episomal chromatin in primate muscle","volume":"82","author":"Penaud-Budloo","year":"2008","journal-title":"J. Virology"},{"key":"B27","doi-asserted-by":"publisher","first-page":"e0280242","DOI":"10.1371\/journal.pone.0280242","article-title":"Genome concentration, characterization, and integrity analysis of recombinant adeno-associated viral vectors using droplet digital PCR","volume":"18","author":"Prantner","year":"2023","journal-title":"PLOS ONE"},{"key":"B28","doi-asserted-by":"publisher","first-page":"3515","DOI":"10.1016\/j.ymthe.2022.09.015","article-title":"\u2018AAV vectors: the Rubik\u2019s cube of human gene therapy","volume":"30","author":"Pupo","year":"2022","journal-title":"Mol. Ther."},{"key":"B29","doi-asserted-by":"publisher","first-page":"095513","DOI":"10.1101\/pdb.top095513","article-title":"Introducing genes into mammalian cells: viral vectors","volume":"2020","author":"Sena-Esteves","year":"2020","journal-title":"Cold Spring Harb. Protoc."},{"key":"B30","volume-title":"Toxicity risks of adeno-associated virus (AAV) vectors for gene therapy (GT)","author":"Sherafat","year":"2021"},{"key":"B31","doi-asserted-by":"publisher","first-page":"12817","DOI":"10.1021\/acs.analchem.1c02828","article-title":"A native mass spectrometry-based assay for rapid assessment of the empty:full capsid ratio in adeno-associated virus gene therapy products","volume":"93","author":"Strasser","year":"2021","journal-title":"Anal. Chem."},{"key":"B32","doi-asserted-by":"publisher","first-page":"21670","DOI":"10.1038\/s41598-023-48901-z","article-title":"AAV production in stable packaging cells requires expression of adenovirus 22\/33K protein to allow episomal amplification of integrated rep\/cap genes","volume":"13","author":"Su","year":"2023","journal-title":"Sci. Rep."},{"key":"B33","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.omtm.2023.07.007","article-title":"Partial genome content within rAAVs impacts performance in a cell assay-dependent manner","volume":"30","author":"Troxell","year":"","journal-title":"Mol. Ther. - Methods and Clin. Dev."},{"key":"B34","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1089\/hum.2022.218","article-title":"Application of size exclusion chromatography with multiangle light scattering in the analytical development of a preclinical stage gene therapy program","volume":"34","author":"Troxell","year":"","journal-title":"Hum. Gene Ther."},{"key":"B35","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1016\/j.ymthe.2005.11.024","article-title":"Removal of empty capsids from type 1 adeno-associated virus vector stocks by anion-exchange chromatography potentiates transgene expression","volume":"13","author":"Urabe","year":"2006","journal-title":"Mol. Ther."},{"key":"B36","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.omtm.2019.09.006","article-title":"Developing an anion exchange chromatography assay for determining empty and full capsid contents in AAV6.2","volume":"15","author":"Wang","year":"2019","journal-title":"Mol. Ther. - Methods and Clin. Dev."},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.4172\/1747-0862.1000175","article-title":"The adeno-associated virus genome packaging puzzle","volume":"9","author":"Wang","year":"2015","journal-title":"J. Mol. Genet. Med."},{"key":"B38","doi-asserted-by":"publisher","first-page":"80","DOI":"10.3390\/biomedicines2010080","article-title":"Product-related impurities in clinical-grade recombinant AAV vectors: characterization and risk assessment","volume":"2","author":"Wright","year":"2014","journal-title":"Biomedicines"},{"key":"B39","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1089\/hum.2021.182","article-title":"Insight and development of advanced recombinant adeno-associated virus analysis tools exploiting single-particle quantification by multidimensional droplet digital PCR","volume":"33","author":"Zanker","year":"2022","journal-title":"Hum. Gene Ther."},{"key":"B40","doi-asserted-by":"publisher","first-page":"e10258","DOI":"10.1002\/btm2.10258","article-title":"Viral vector\u2010based gene therapies in the clinic","volume":"7","author":"Zhao","year":"2022","journal-title":"Bioeng. and Transl. Med."},{"key":"B41","doi-asserted-by":"publisher","first-page":"16428","DOI":"10.1021\/acsomega.1c01443","article-title":"Adeno-associated virus virus-like particle characterization via orthogonal methods: nanoelectrospray differential mobility analysis, asymmetric flow field-flow fractionation, and atomic force microscopy","volume":"6","author":"Zoratto","year":"2021","journal-title":"ACS Omega"}],"container-title":["Frontiers in Bioengineering and Biotechnology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fbioe.2024.1436857\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T04:42:21Z","timestamp":1727757741000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fbioe.2024.1436857\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,1]]},"references-count":44,"alternative-id":["10.3389\/fbioe.2024.1436857"],"URL":"https:\/\/doi.org\/10.3389\/fbioe.2024.1436857","relation":{},"ISSN":["2296-4185"],"issn-type":[{"value":"2296-4185","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,1]]},"article-number":"1436857"}}